Shubham Singh

Two amendments to India's Medical Devices Rules, 2017, were positioned as pro-business. The reaction from industry suggests they landed differently depending on which side of the import ledger a manufacturer sits on.

Chirag Patel built BAiO around deliberate constraints — no diagnosis, no prediction, no autonomous decisions — and is frank that the category it sits in earned its skepticism long before BAiO arrived.

A Pew survey of 3,488 US adults finds 72% want to be told if AI is used in their care and 46% do not know if it has already happened — a transparency gap that may matter more to public trust in healthcare AI than adoption rates alone.

ARPA-H is funding four competing teams to solve the same problem — too few stroke specialists, too far from too many patients — and Philips' $33.7m award is the latest piece of a $175m bet on autonomous endovascular robotics.

Medtronic has found a way to compete in surgical robotics and structural heart without making an all-or-nothing bet in either — two deals announced this quarter that look different on the surface but are built on the same logic: minimum commitment now, maximum optionality later.

Boston Scientific says its Aug. 25 cybersecurity incident is still under investigation, with manufacturing and order fulfillment disrupted, new remote monitoring activations blocked, and no confirmed timeline yet for full restoration.

AZB & Partners advised SkyPower Services MENA and Inox Clean Energy on the development of one of the largest solar power projects in Matobo, Zimbabwe.

Stryker is acquiring ZuriMED and its FiberLocker System less than a year after US launch, betting that mechanical augmentation at the suture-tendon interface can address a retear rate that runs as high as 94% in some populations.

Medtech’s largest players are not waiting for conditions to improve before deploying capital — Stryker, Boston Scientific, Medtronic and Zimmer Biomet all signaled accelerating deal activity this earnings season, each with a distinct playbook for what to buy and when.

Large CSV files often contain repeated customer records, duplicate email addresses, or identical rows after data exports and migrations.